BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 26146760)

  • 1. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.
    Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM
    Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?
    Kilpatrick SE
    Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.
    Brisson M; Kashima T; Delaney D; Tirabosco R; Clarke A; Cro S; Flanagan AM; O'Donnell P
    Skeletal Radiol; 2013 May; 42(5):635-47. PubMed ID: 22987247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learnt from MDM2 fluorescence in-situ hybridisation analysis of 439 mature lipomatous lesions with an emphasis on atypical lipomatous tumour/well-differentiated liposarcoma lacking cytological atypia.
    Vargas AC; Joy C; Cheah AL; Jones M; Bonar F; Brookwell R; Garrone B; Talbot J; Harraway J; Gill AJ; Maclean FM
    Histopathology; 2022 Jan; 80(2):369-380. PubMed ID: 34523152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
    Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
    Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 RNA In Situ Hybridization for the Diagnosis of Atypical Lipomatous Tumor: A Study Evaluating DNA, RNA, and Protein Expression.
    Kulkarni AS; Wojcik JB; Chougule A; Arora K; Chittampalli Y; Kurzawa P; Mullen JT; Chebib I; Nielsen GP; Rivera MN; Ting DT; Deshpande V
    Am J Surg Pathol; 2019 Apr; 43(4):446-454. PubMed ID: 30520819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.
    Ng W; Messiou C; Smith M; Thway K
    Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma by cytological analysis.
    Sugiyama K; Washimi K; Sato S; Hiruma T; Sakai M; Okubo Y; Miyagi Y; Yokose T
    Diagn Cytopathol; 2022 Mar; 50(3):112-122. PubMed ID: 34984861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status.
    Knebel C; Neumann J; Schwaiger BJ; Karampinos DC; Pfeiffer D; Specht K; Lenze U; von Eisenhart-Rothe R; Rummeny EJ; Woertler K; Gersing AS
    BMC Cancer; 2019 Apr; 19(1):309. PubMed ID: 30943944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 FISH testing criteria in adipose tissue tumors with mature adipocytic morphology - A resection case-based study.
    Li L; Yue P; Du Q; Zhang H; Song Y
    Pathol Res Pract; 2024 Jan; 253():155039. PubMed ID: 38134838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endobronchial lipomatous tumors: clinicopathologic analysis of 12 cases with molecular cytogenetic evidence supporting classification as "lipoma".
    Boland JM; Fritchie KJ; Erickson-Johnson MR; Oliveira AM; Colby TV; Folpe AL
    Am J Surg Pathol; 2013 Nov; 37(11):1715-21. PubMed ID: 24121172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
    Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
    Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of lipoma and atypical lipomatous tumor by a scoring system: implication of increased vascularity on pathogenesis of liposarcoma.
    Nagano S; Yokouchi M; Setoguchi T; Ishidou Y; Sasaki H; Shimada H; Komiya S
    BMC Musculoskelet Disord; 2015 Feb; 16():36. PubMed ID: 25879189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26.
    Gardner JM; Dandekar M; Thomas D; Goldblum JR; Weiss SW; Billings SD; Lucas DR; McHugh JB; Patel RM
    Am J Surg Pathol; 2012 Jul; 36(7):1047-51. PubMed ID: 22472959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
    Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW
    Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
    Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
    Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.